And it looks like it is way more reliable than 177Lu...
The FDA has granted Fast Track Designation to 67Cu-SAR-bisPSMA, a novel radiopharmaceutical therapy for metastatic castration-resistant prostate cancer (mCRPC). Preliminary data from the SECuRE trial show promising results, with 73% of patients experiencing PSA reductions and 45% seeing drops greater than 50%. Notably, a patient who received two doses of 8 GBq 67Cu-SAR-bisPSMA achieved complete remission, with undetectable PSA levels for 13 months.
Final trial results are expected in September 2026, and continued remission in early responders could signal a breakthrough for advanced prostate cancer treatment.
I don't think they'd let you do both currently. What they're reporting out so far seems similar in terms of percentages of any response and PSA50. Cu-67 seems like maybe fewer side effects?
Who knows? I know that today my psa went from 0.01 to 0.02 and I was almost freaking out!!! But then the nurse interviewed me and she said that not drinking anything for 10 hours before having my blood drawn is not a brilliant idea if i want reliable results! (I was in a hurry so like 5 minutes after waking up I was already in the car!)
Seriously, I will check, but when they talk about complete remission it usually means that it's not visible on the scans. If I remember correctly they have published also the guy's scan to show the response.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.